Global Coronary Catheters Market 2024-2030

    In Stock

    CORONARY CATHETERS MARKET

     

    INTRODUCTION

    A minimally invasive procedure called a cardiac catheterization uses a catheter to get access to the heart’s blood-filled chambers and coronary circulation. It is done for both interventional and diagnostic purposes.

     

    One of the many diagnostic procedures and tests used in cardiology is coronary catheterization.

     

    Angiocardiography specifically enables the identification of occlusion, stenosis, restenosis, thrombosis, or aneurysmal enlargement of the coronary artery lumens, heart chamber size, heart muscle contraction performance, and some aspects of heart valve function through the injection of a liquid radiocontrast agent and illumination with X-rays.

     

    infography; Coronary Catheters Market, Coronary Catheters Market Size, Coronary Catheters Market Trends, Coronary Catheters Market Forecast, Coronary Catheters Market Risks, Coronary Catheters Market Report, Coronary Catheters Market Share

     

    For up to 2-3% of patients, cardiac catheterization frequently required multiple hours and resulted in serious consequences.

     

    Simple coronary catheterization tests are now routinely performed more quickly and with noticeably better results because of numerous incremental advancements throughout time.

     

    CORONARY CATHETERS MARKET SIZE AND FORECAST

     

    The Global Coronary Catheters market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

     

    CORONARY CATHETERS MARKET NEW PRODUCT LAUNCH

    The iCross Coronary Imaging Catheter, a product or tool created to enhance the deliverability of the company’s market-leading intravascular ultrasound  technology, the iLab Ultrasound Imaging System, was introduced today by Boston Scientific Corporation.

     

    Doctors may view precise images of the heart and coronary arteries inside the body thanks to IVUS technology. The iCross Catheter will be readily available in the United States, according to the company.

     

    The iCross Coronary Imaging Catheter from Boston Scientific is an effective tool for identifying coronary intravascular pathology, particularly in individuals with complicated coronary artery disease.

     

    They anticipate that the enhancements iCross provides to doctors and their patients will further bolster our dominance in intravascular ultrasonography. A wide variety of interventional medical specialties employ products developed, produced, and marketed by Boston Scientific on a global scale.

     

    The XO Cross Support Catheter Platform from Transit Scientific has received FDA approval for coronary usage. The platform is intended to facilitate wire exchanges, provide a conduit for the supply of saline solutions or diagnostic contrast agents, and guide and support a guidewire during access of the peripheral or coronary arteries.

     

    The XO Cross Support Catheter platform is made to offer new degrees of pushability, trackability, flexibility, and torque responsiveness for access in tortuosity and difficult lesions. High fatigue resistance against challenging complicated lesions present in advanced coronary artery disease (CAD), peripheral artery disease (PAD), and critical limb ischemia is provided by the non-tapered metal-alloy and polymer construction (CLI).

     

    The Prevail drug coated balloon (DCB) Catheter has been introduced in Europe under the CE (Conformité Européenne) label, according to an announcement from Medtronic plc, the world leader in medical technology.

     

    The Prevail DCB, which is the most recent coronary DCB on the market, is used during percutaneous coronary intervention (PCI) operations to treat blocked or restricted coronary arteries in people with coronary artery disease (CAD). The Prevail DCB treats de novo lesions, small vascular disease, and in-stent restenosis using paclitaxel, a medication with fast absorption (ISR).

     

    CORONARY CATHETERS MARKET NEW PRODUCT LAUNCH

     

    CARDIAC CATHETERS 

     

    Biosense Webster, a Johnson & Johnson MedTech business, has introduced the Octaray, an eight-spline mapping catheter.A new cardiac mapping device developed by Biosense Webster could help electrophysiologists map cardiac arrhythmias more accurately and effectively.

     

    Biosense, a division of Johnson & Johnson MedTech, has introduced the Octaray Mapping Catheter with Trueref technology driven by the Carto 3 Version 7 System. The novel cardiac mapping catheter was designed for the mapping of cardiac arrhythmias such as atrial fibrillation (AFib).

     

    According to the business, the catheter contains eight splines with enhanced electrode spacing possibilities for quicker and more efficient mapping periods than the Pentaray Nav Eco Mapping Catheter, which may shorten overall ablation operation time frames.

     

    According to the business, the catheter contains eight splines with enhanced electrode spacing possibilities for quicker and more efficient mapping periods than the Pentaray Nav Eco Mapping Catheter, which may shorten overall ablation operation timeframes.

     

    The Octaray is designed to map arrhythmias in any chamber and to provide physicians with greater clarity, speed, and integration to collect exact information for catheter ablation operations.

     

    The device has been approved by the FDA and is CE marked.The Octaray Mapping Catheter’s greater surface area coverage and higher signal quality with more splines and electrodes helps me to better understand the anatomy and conduction qualities of the chamber of interest.

     

    “Not only does this catheter help me map more accurately and efficiently, but it also allows for more patient-specific therapy.” Trueref technology is a mapping reference electrode that is intended to lessen the effect of farfield signals.

     

    The catheter features 48 tiny mapping electrodes on eight splines, a smaller electrode size, and close electrode spacing. In comparison to the Pentaray Nav Eco, the new cardiac mapping catheter is meant to reliably identify lesion set gaps and improve characterisation of lesion sets. According to Biosense, the Octaray catheter enables for more precise and detailed mapping while improving signal quality.

     

    CORONARY CATHETERS MARKET COMPANY PROFILES

     

    THIS CORONARY CATHETERS MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. How many Coronary Catheters Markets are manufactured per annum in Globally ? WHo are tHe sub-component suppliers in different regions?
    2. Cost breakup of a Coronary Catheters Market and key vendor selection criteria
    3. WHere is the Coronary Catheters Market manufactured? WHat is tHe average margin per unit?
    4. Market sHare of Coronary Catheters Market manufacturers and tHeir upcoming products
    5. Cost advantage for OEMs wHo manufacture Coronary Catheters Market  in-House
    6. key predictions for next 5 years in Coronary Catheters  
    7. Average B-2-Bl Coronary Catheters Market   price in all segments
    8. Latest trends in Coronary Catheters Market ,by every market segment
    9. THe market size (botH volume and value) of tHe Coronary Catheters Market  in 2024-2030 and every year in between?
    10. Production Coronary Catheters Market ,by suppliers and tHeir OEM relationsHip

     

    Market Segmentation
    Scope of the report
    Abbreviations
    Research Methodology
    Executive Summary
    Introduction
    Insights from Industry stakeholders
    Cost breakdown of Product by sub-components and average profit margin
    Disruptive innovation in the Industry
    Technology trends in the Industry
    Consumer trends in the industry
    Recent Production Milestones
    Component Manufacturing in US, EU and China
    COVID-19 impact on overall market
    COVID-19 impact on Production of components
    COVID-19 impact on Point of sale
    Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    Product installation rate by OEM, 2023
    Incline/Decline in Average B-2-B selling price in past 5 years
    Competition from substitute products
    Gross margin and average profitability of suppliers
    New product development in past 12 months
    M&A in past 12 months
    Growth strategy of leading players
    Market share of vendors, 2023
    Company Profiles
    Unmet needs and opportunity for new suppliers
    Conclusion
    Appendix
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop